Maternal body mass index, excess gestational weight gain, and diabetes are positively associated with neonatal adiposity in the Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) study.


Journal

Pediatric obesity
ISSN: 2047-6310
Titre abrégé: Pediatr Obes
Pays: England
ID NLM: 101572033

Informations de publication

Date de publication:
04 2019
Historique:
received: 21 05 2018
revised: 27 09 2018
accepted: 03 10 2018
pubmed: 17 1 2019
medline: 4 6 2019
entrez: 17 1 2019
Statut: ppublish

Résumé

In-utero exposures likely influence the onset and severity of obesity in youth. With increasing rates of type 2 diabetes mellitus (T2DM) and maternal adiposity in pregnancy globally, it is important to assess the impact of these factors on neonatal adipose measures. To evaluate the contribution of maternal ethnicity, body mass index (BMI), gestational weight gain, and hyperglycaemia to neonatal adiposity. Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) is a longitudinal cohort study of Australian mother and neonate pairs. In this analysis, Indigenous (n = 519) and Europid (n = 358) women were included, of whom 644 had hyperglycaemia (type 2 diabetes [T2DM], diabetes in pregnancy [DIP], or gestational diabetes [GDM]). Associations between maternal ethnicity, hyperglycaemia, BMI and gestational weight gain, and the neonatal outcomes of length, head circumference, sum of skinfolds, total body fat, and percentage body fat were examined. Models were adjusted for maternal age, smoking status, parity, education, neonatal gender, and gestational age. Among those with hyperglycaemia in pregnancy, Indigenous women had a higher proportion of T2DM and DIP (36%, 13%) compared with Europid women (4%, 3%). In multivariate analysis, maternal T2DM (compared with no hyperglycaemia), BMI during pregnancy, and excess compared with appropriate gestational weight gain, were significantly associated with greater neonatal measures. DIP was associated with greater sum of skinfolds, total body fat, and percentage body fat. Indigenous ethnicity was associated with greater sum of skinfolds. Maternal BMI, excess gestational weight gain, and hyperglycaemia operated as independent factors influencing neonatal adiposity. Interventions addressing these factors are needed to reduce neonatal adiposity.

Sections du résumé

BACKGROUND
In-utero exposures likely influence the onset and severity of obesity in youth. With increasing rates of type 2 diabetes mellitus (T2DM) and maternal adiposity in pregnancy globally, it is important to assess the impact of these factors on neonatal adipose measures.
OBJECTIVES
To evaluate the contribution of maternal ethnicity, body mass index (BMI), gestational weight gain, and hyperglycaemia to neonatal adiposity.
METHODS
Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) is a longitudinal cohort study of Australian mother and neonate pairs. In this analysis, Indigenous (n = 519) and Europid (n = 358) women were included, of whom 644 had hyperglycaemia (type 2 diabetes [T2DM], diabetes in pregnancy [DIP], or gestational diabetes [GDM]). Associations between maternal ethnicity, hyperglycaemia, BMI and gestational weight gain, and the neonatal outcomes of length, head circumference, sum of skinfolds, total body fat, and percentage body fat were examined. Models were adjusted for maternal age, smoking status, parity, education, neonatal gender, and gestational age.
RESULTS
Among those with hyperglycaemia in pregnancy, Indigenous women had a higher proportion of T2DM and DIP (36%, 13%) compared with Europid women (4%, 3%). In multivariate analysis, maternal T2DM (compared with no hyperglycaemia), BMI during pregnancy, and excess compared with appropriate gestational weight gain, were significantly associated with greater neonatal measures. DIP was associated with greater sum of skinfolds, total body fat, and percentage body fat. Indigenous ethnicity was associated with greater sum of skinfolds.
CONCLUSIONS
Maternal BMI, excess gestational weight gain, and hyperglycaemia operated as independent factors influencing neonatal adiposity. Interventions addressing these factors are needed to reduce neonatal adiposity.

Identifiants

pubmed: 30650263
doi: 10.1111/ijpo.12490
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12490

Subventions

Organisme : National Health and Medical Research Council of Australia
ID : 1032216
Pays : International
Organisme : National Health and Medical Research Council of Australia
ID : 1038372
Pays : International
Organisme : National Health and Medical Research Council of Australia
ID : 1078333
Pays : International
Organisme : National Health and Medical Research Council of Australia
ID : 1078477
Pays : International
Organisme : National Health and Medical Research Council of Australia
ID : 1079438
Pays : International
Organisme : National Health and Medical Research Council of Australia
ID : 605837
Pays : International
Organisme : National Health and Medical Research Council of Australia
ID : 1032116
Pays : International
Organisme : National Heart Foundation
ID : 101291
Pays : International

Informations de copyright

© 2019 World Obesity Federation.

Auteurs

Danielle K Longmore (DK)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.
Department of Paediatrics, Western Health, Melbourne, Australia.

Elizabeth L M Barr (ELM)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia.

I-Lynn Lee (IL)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.

Federica Barzi (F)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.

Marie Kirkwood (M)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.

Cherie Whitbread (C)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.
Division of Medicine, Royal Darwin Hospital, Darwin, Australia.

Vanya Hampton (V)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.

Sian Graham (S)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.

Paula Van Dokkum (P)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.
Baker Heart and Diabetes Institute, Alice Springs, Australia.

Christine Connors (C)

Northern Territory Department of Health, Darwin, Australia.

Jacqueline A Boyle (JA)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Patrick Catalano (P)

Tufts University School of Medicine, Boston, Massachusetts.

Alex D H Brown (ADH)

South Australian Health and Medical Research Institute, Adelaide, Australia.

Kerin O'Dea (K)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.

Jeremy Oats (J)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

H David McIntyre (HD)

Mater Medical Research Institute, University of Queensland, Brisbane, Australia.

Jonathan E Shaw (JE)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Louise J Maple-Brown (LJ)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Australia.
Division of Medicine, Royal Darwin Hospital, Darwin, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH